Nicox Announces Approval of ZERVIATE in China

Press ReleaseNicox Announces Approval of ZERVIATE in China Nicox's partner, Ocumension Therapeutics, has received approval for ZERVIATE ®for ocular itching in China ZERVIATE ®launch in China will add a further royalty revenue stream for NicoxSeptember 18, 2024 – release at 7:30 am CETSophia Antipolis, France Nicox SA(Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced that its exclusive Chinese...

Biot, 18/09/2024 (informazione.news - comunicati stampa - salute e benessere)

 

Zhaoke Ophthalmology Limited IPO Prospectus, April 2021

Attachment